Loading...
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma A Review
IMPORTANCE: For more than a decade, sorafenib has been the only systemic treatment option for patients with advanced hepatocellular carcinoma (HCC). However, rapid progress over the past few years led to approval of other angiogenesis inhibitors and several immune checkpoint blockers (ICBs) that hav...
Na minha lista:
| Udgivet i: | JAMA Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265820/ https://ncbi.nlm.nih.gov/pubmed/33090190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.3381 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|